Balyasny Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.65M | Buy |
|
|||||
|
2025
Q1 | $9.24M | Buy |
|
|||||
|
2024
Q4 | $7.57M | Sell |
|
|||||
|
2024
Q3 | $70.5M | Sell |
|
|||||
|
2024
Q2 | $89.6M | Buy |
|
|||||
|
2024
Q1 | $415K | Sell |
|
|||||
|
2023
Q4 | $1.79M | Sell |
|
|||||
|
2023
Q3 | $1.69M | Sell |
|
|||||
|
2023
Q2 | $1.81M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $37.4M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $23M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $2.55M | Sell |
|
|||||
|
2021
Q2 | $9.5M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $13M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $21.5M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $791K | Sell |
|
|||||
|
2019
Q1 | $1.17M | Sell |
|
|||||
|
2018
Q4 | $12.3M | Buy |
|
|||||
|
2018
Q3 | $3.37M | Sell |
|
|||||
|
2018
Q2 | $4.61M | Sell |
|
|||||
|
2018
Q1 | $4.98M | Buy |
|
|||||
|
2017
Q4 | $720K | Sell |
|
|||||
|
2017
Q3 | $5.42M | Sell |
|
|||||
|
2017
Q2 | $11M | Buy |
|
|||||
|
2017
Q1 | $1.51M | Sell |
|
|||||
|
2016
Q4 | $5.54M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $687K | Sell |
|
|||||
|
2015
Q4 | $758K | Buy |
|